APO Research
Talk to an analyst

APO RESEARCH · REPORT

Diltiazem Hydrochloride Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Diltiazem Hydrochloride Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025191 pages

Choose your research edition.

Industry ResearchDiltiazem Hydrochloride Injection Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Diltiazem Hydrochloride Injection Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Diltiazem Hydrochloride Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Diltiazem Hydrochloride Injection Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Diltiazem Hydrochloride Injection Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Diltiazem Hydrochloride Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Diltiazem Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Diltiazem Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Diltiazem Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Diltiazem Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Diltiazem Hydrochloride Injection include Zhejiang Yatai Pharmaceutical, Shanghai Pharmaceuticals, SHANDONG FANGMING BANGJIA PHARMACEUTICAL, Mylan Pharmaceuticals, JiangSu WuZhong Pharmaceutical, Pfizer, Torrent Pharmaceuticals, SGPharma and SagentPharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Diltiazem Hydrochloride Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Diltiazem Hydrochloride Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Diltiazem Hydrochloride Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Diltiazem Hydrochloride Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Diltiazem Hydrochloride Injection Segment by Company

Zhejiang Yatai Pharmaceutical

Shanghai Pharmaceuticals

SHANDONG FANGMING BANGJIA PHARMACEUTICAL

Mylan Pharmaceuticals

JiangSu WuZhong Pharmaceutical

Pfizer

Torrent Pharmaceuticals

SGPharma

SagentPharma

Nova Plus Pharmaceuticals

Hikma Pharmaceuticals

Eugia US

AdvaCare Pharma

Diltiazem Hydrochloride Injection Segment by Type

10mg/1ml

10mg/2ml

Diltiazem Hydrochloride Injection Segment by Application

Cardiovascular System Diseases

Surgery-Related Applications

Diltiazem Hydrochloride Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diltiazem Hydrochloride Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Diltiazem Hydrochloride Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diltiazem Hydrochloride Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Diltiazem Hydrochloride Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Diltiazem Hydrochloride Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Diltiazem Hydrochloride Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Diltiazem Hydrochloride Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Diltiazem Hydrochloride Injection Industry Trends Table 2. Diltiazem Hydrochloride Injection Industry Drivers Table 3. Diltiazem Hydrochloride Injection Industry Opportunities and Challenges Table 4. Diltiazem Hydrochloride Injection Industry Restraints Table 5. Global Diltiazem Hydrochloride Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Diltiazem Hydrochloride Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Diltiazem Hydrochloride Injection Sales by Manufacturers (L) & (2021-2026) Table 8. Global Diltiazem Hydrochloride Injection Sales Market Share by Manufacturers Table 9. Global Diltiazem Hydrochloride Injection Average Sales Price (US$/ml) of Manufacturers (2021-2026) Table 10. Global Diltiazem Hydrochloride Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Diltiazem Hydrochloride Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Diltiazem Hydrochloride Injection Manufacturers, Product Type & Application Table 13. Global Diltiazem Hydrochloride Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Diltiazem Hydrochloride Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 10mg/1ml Table 17. Major Manufacturers of 10mg/2ml Table 18. Global Diltiazem Hydrochloride Injection Sales by Type 2021 VS 2025 VS 2032 (L) Table 19. Global Diltiazem Hydrochloride Injection Sales by Type (2021-2026) & (L) Table 20. Global Diltiazem Hydrochloride Injection Sales by Type (2027-2032) & (L) Table 21. Global Diltiazem Hydrochloride Injection Sales Market Share by Type (2021-2026) Table 22. Global Diltiazem Hydrochloride Injection Sales Market Share by Type (2027-2032) Table 23. Global Diltiazem Hydrochloride Injection Revenue by Type 2021 VS 2025 VS 2032 (L) Table 24. Global Diltiazem Hydrochloride Injection Revenue by Type (2021-2026) & (L) Table 25. Global Diltiazem Hydrochloride Injection Revenue by Type (2027-2032) & (L) Table 26. Global Diltiazem Hydrochloride Injection Revenue Market Share by Type (2021-2026) Table 27. Global Diltiazem Hydrochloride Injection Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Cardiovascular System Diseases Table 29. Major Manufacturers of Surgery-Related Applications Table 30. Global Diltiazem Hydrochloride Injection Sales by Application 2021 VS 2025 VS 2032 (L) Table 31. Global Diltiazem Hydrochloride Injection Sales by Application (2021-2026) & (L) Table 32. Global Diltiazem Hydrochloride Injection Sales by Application (2027-2032) & (L) Table 33. Global Diltiazem Hydrochloride Injection Sales Market Share by Application (2021-2026) Table 34. Global Diltiazem Hydrochloride Injection Sales Market Share by Application (2027-2032) Table 35. Global Diltiazem Hydrochloride Injection Revenue by Application 2021 VS 2025 VS 2032 (L) Table 36. Global Diltiazem Hydrochloride Injection Revenue by Application (2021-2026) & (L) Table 37. Global Diltiazem Hydrochloride Injection Revenue by Application (2027-2032) & (L) Table 38. Global Diltiazem Hydrochloride Injection Revenue Market Share by Application (2021-2026) Table 39. Global Diltiazem Hydrochloride Injection Revenue Market Share by Application (2027-2032) Table 40. Global Diltiazem Hydrochloride Injection Sales by Region: 2021 VS 2025 VS 2032 (L) Table 41. Global Diltiazem Hydrochloride Injection Sales by Region (2021-2026) & (L) Table 42. Global Diltiazem Hydrochloride Injection Sales Market Share by Region (2021-2026) Table 43. Global Diltiazem Hydrochloride Injection Sales Forecasted by Region (2027-2032) & (L) Table 44. Global Diltiazem Hydrochloride Injection Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Diltiazem Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 46. North America Diltiazem Hydrochloride Injection Sales by Country (2021-2026) & (L) Table 47. North America Diltiazem Hydrochloride Injection Sales by Country (2027-2032) & (L) Table 48. Europe Diltiazem Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 49. Europe Diltiazem Hydrochloride Injection Sales by Country (2021-2026) & (L) Table 50. Europe Diltiazem Hydrochloride Injection Sales by Country (2027-2032) & (L) Table 51. Asia Pacific Diltiazem Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 52. Asia Pacific Diltiazem Hydrochloride Injection Sales by Country (2021-2026) & (L) Table 53. Asia Pacific Diltiazem Hydrochloride Injection Sales by Country (2027-2032) & (L) Table 54. South America, Middle East and Africa Diltiazem Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 55. South America, Middle East and Africa Diltiazem Hydrochloride Injection Sales by Country (2021-2026) & (L) Table 56. South America, Middle East and Africa Diltiazem Hydrochloride Injection Sales by Country (2027-2032) & (L) Table 57. Global Diltiazem Hydrochloride Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Diltiazem Hydrochloride Injection Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Diltiazem Hydrochloride Injection Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Diltiazem Hydrochloride Injection Revenue Market Share by Region (2021-2026) Table 61. Global Diltiazem Hydrochloride Injection Revenue Market Share by Region (2027-2032) Table 62. Zhejiang Yatai Pharmaceutical Company Information Table 63. Zhejiang Yatai Pharmaceutical Business Overview Table 64. Zhejiang Yatai Pharmaceutical Diltiazem Hydrochloride Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Zhejiang Yatai Pharmaceutical Diltiazem Hydrochloride Injection Product Portfolio Table 66. Zhejiang Yatai Pharmaceutical Recent Development Table 67. Shanghai Pharmaceuticals Company Information Table 68. Shanghai Pharmaceuticals Business Overview Table 69. Shanghai Pharmaceuticals Diltiazem Hydrochloride Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Shanghai Pharmaceuticals Diltiazem Hydrochloride Injection Product Portfolio Table 71. Shanghai Pharmaceuticals Recent Development Table 72. SHANDONG FANGMING BANGJIA PHARMACEUTICAL Company Information Table 73. SHANDONG FANGMING BANGJIA PHARMACEUTICAL Business Overview Table 74. SHANDONG FANGMING BANGJIA PHARMACEUTICAL Diltiazem Hydrochloride Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. SHANDONG FANGMING BANGJIA PHARMACEUTICAL Diltiazem Hydrochloride Injection Product Portfolio Table 76. SHANDONG FANGMING BANGJIA PHARMACEUTICAL Recent Development Table 77. Mylan Pharmaceuticals Company Information Table 78. Mylan Pharmaceuticals Business Overview Table 79. Mylan Pharmaceuticals Diltiazem Hydrochloride Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Mylan Pharmaceuticals Diltiazem Hydrochloride Injection Product Portfolio Table 81. Mylan Pharmaceuticals Recent Development Table 82. JiangSu WuZhong Pharmaceutical Company Information Table 83. JiangSu WuZhong Pharmaceutical Business Overview Table 84. JiangSu WuZhong Pharmaceutical Diltiazem Hydrochloride Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. JiangSu WuZhong Pharmaceutical Diltiazem Hydrochloride Injection Product Portfolio Table 86. JiangSu WuZhong Pharmaceutical Recent Development Table 87. Pfizer Company Information Table 88. Pfizer Business Overview Table 89. Pfizer Diltiazem Hydrochloride Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Pfizer Diltiazem Hydrochloride Injection Product Portfolio Table 91. Pfizer Recent Development Table 92. Torrent Pharmaceuticals Company Information Table 93. Torrent Pharmaceuticals Business Overview Table 94. Torrent Pharmaceuticals Diltiazem Hydrochloride Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Torrent Pharmaceuticals Diltiazem Hydrochloride Injection Product Portfolio Table 96. Torrent Pharmaceuticals Recent Development Table 97. SGPharma Company Information Table 98. SGPharma Business Overview Table 99. SGPharma Diltiazem Hydrochloride Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. SGPharma Diltiazem Hydrochloride Injection Product Portfolio Table 101. SGPharma Recent Development Table 102. SagentPharma Company Information Table 103. SagentPharma Business Overview Table 104. SagentPharma Diltiazem Hydrochloride Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. SagentPharma Diltiazem Hydrochloride Injection Product Portfolio Table 106. SagentPharma Recent Development Table 107. Nova Plus Pharmaceuticals Company Information Table 108. Nova Plus Pharmaceuticals Business Overview Table 109. Nova Plus Pharmaceuticals Diltiazem Hydrochloride Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Nova Plus Pharmaceuticals Diltiazem Hydrochloride Injection Product Portfolio Table 111. Nova Plus Pharmaceuticals Recent Development Table 112. Hikma Pharmaceuticals Company Information Table 113. Hikma Pharmaceuticals Business Overview Table 114. Hikma Pharmaceuticals Diltiazem Hydrochloride Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Hikma Pharmaceuticals Diltiazem Hydrochloride Injection Product Portfolio Table 116. Hikma Pharmaceuticals Recent Development Table 117. Eugia US Company Information Table 118. Eugia US Business Overview Table 119. Eugia US Diltiazem Hydrochloride Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Eugia US Diltiazem Hydrochloride Injection Product Portfolio Table 121. Eugia US Recent Development Table 122. AdvaCare Pharma Company Information Table 123. AdvaCare Pharma Business Overview Table 124. AdvaCare Pharma Diltiazem Hydrochloride Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. AdvaCare Pharma Diltiazem Hydrochloride Injection Product Portfolio Table 126. AdvaCare Pharma Recent Development Table 127. Key Raw Materials Table 128. Raw Materials Key Suppliers Table 129. Diltiazem Hydrochloride Injection Distributors List Table 130. Diltiazem Hydrochloride Injection Customers List Table 131. Research Programs/Design for This Report Table 132. Authors List of This Report Table 133. Secondary Sources Table 134. Primary Sources List of Figures Figure 1. Diltiazem Hydrochloride Injection Product Image Figure 2. Global Diltiazem Hydrochloride Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Diltiazem Hydrochloride Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Diltiazem Hydrochloride Injection Sales (2021-2032) & (L) Figure 5. Global Diltiazem Hydrochloride Injection Average Price (US$/ml) & (2021-2032) Figure 6. Global Top 5 and 10 Diltiazem Hydrochloride Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 10mg/1ml Image Figure 9. 10mg/2ml Image Figure 10. Global Diltiazem Hydrochloride Injection Sales by Type (2021 VS 2025 VS 2032) & (L) Figure 11. Global Diltiazem Hydrochloride Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Diltiazem Hydrochloride Injection Sales Market Share by Type (2021-2032) Figure 13. Global Diltiazem Hydrochloride Injection Revenue by Type (2021 VS 2025 VS 2032) & (L) Figure 14. Global Diltiazem Hydrochloride Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Diltiazem Hydrochloride Injection Revenue Market Share by Type (2021-2032) Figure 16. Cardiovascular System Diseases Image Figure 17. Surgery-Related Applications Image Figure 18. Global Diltiazem Hydrochloride Injection Sales by Application (2021 VS 2025 VS 2032) & (L) Figure 19. Global Diltiazem Hydrochloride Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Diltiazem Hydrochloride Injection Sales Market Share by Application (2021-2032) Figure 21. Global Diltiazem Hydrochloride Injection Revenue by Application (2021 VS 2025 VS 2032) & (L) Figure 22. Global Diltiazem Hydrochloride Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Diltiazem Hydrochloride Injection Revenue Market Share by Application (2021-2032) Figure 24. North America Diltiazem Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 25. North America Diltiazem Hydrochloride Injection Sales Market Share by Country (2021-2032) Figure 26. U.S. Diltiazem Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 27. Canada Diltiazem Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 28. Mexico Diltiazem Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 29. Europe Diltiazem Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 30. Europe Diltiazem Hydrochloride Injection Sales Market Share by Country (2021-2032) Figure 31. Germany Diltiazem Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 32. France Diltiazem Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 33. U.K. Diltiazem Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 34. Italy Diltiazem Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 35. Netherlands Diltiazem Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 36. Asia Pacific Diltiazem Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 37. Asia Pacific Diltiazem Hydrochloride Injection Sales Market Share by Country (2021-2032) Figure 38. China Diltiazem Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 39. Japan Diltiazem Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 40. South Korea Diltiazem Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 41. Southeast Asia Diltiazem Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 42. India Diltiazem Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 43. Australia Diltiazem Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 44. South America, Middle East and Africa Diltiazem Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 45. South America, Middle East and Africa Diltiazem Hydrochloride Injection Sales Market Share by Country (2021-2032) Figure 46. Brazil Diltiazem Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 47. South Africa Diltiazem Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 48. Saudi Arabia Diltiazem Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 49. Turkey Diltiazem Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 50. Argentina Diltiazem Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 51. UAE Diltiazem Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 52. Egypt Diltiazem Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 53. Chile Diltiazem Hydrochloride Injection Sales and Growth Rate (2021-2032) & (L) Figure 54. Global Diltiazem Hydrochloride Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Diltiazem Hydrochloride Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Diltiazem Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Figure 57. North America Diltiazem Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Diltiazem Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Figure 59. Europe Diltiazem Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Diltiazem Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Diltiazem Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Diltiazem Hydrochloride Injection Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Diltiazem Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Diltiazem Hydrochloride Injection Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Diltiazem Hydrochloride Injection Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 10mg/1ml
  • 10mg/2ml
Applications
  • Cardiovascular System Diseases
  • Surgery-Related Applications
Companies covered
  • Zhejiang Yatai Pharmaceutical
  • Shanghai Pharmaceuticals
  • SHANDONG FANGMING BANGJIA PHARMACEUTICAL
  • Mylan Pharmaceuticals
  • JiangSu WuZhong Pharmaceutical
  • Pfizer
  • Torrent Pharmaceuticals
  • SGPharma
  • SagentPharma
  • Nova Plus Pharmaceuticals
  • Hikma Pharmaceuticals
  • Eugia US
  • AdvaCare Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Diltiazem Hydrochloride Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Diltiazem Hydrochloride Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Diltiazem Hydrochloride Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Diltiazem Hydrochloride Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Diltiazem Hydrochloride Injection Market Dynamics
  1. 2.1 Diltiazem Hydrochloride Injection Industry Trends
  2. 2.2 Diltiazem Hydrochloride Injection Industry Drivers
  3. 2.3 Diltiazem Hydrochloride Injection Industry Opportunities and Challenges
  4. 2.4 Diltiazem Hydrochloride Injection Industry Restraints
3 Diltiazem Hydrochloride Injection Market by Manufacturers
  1. 3.1 Global Diltiazem Hydrochloride Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Diltiazem Hydrochloride Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Diltiazem Hydrochloride Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Diltiazem Hydrochloride Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Diltiazem Hydrochloride Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Diltiazem Hydrochloride Injection Manufacturers, Product Type & Application
  7. 3.7 Global Diltiazem Hydrochloride Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Diltiazem Hydrochloride Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Diltiazem Hydrochloride Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Diltiazem Hydrochloride Injection Tier 1, Tier 2, and Tier 3
4 Diltiazem Hydrochloride Injection Market by Type
  1. 4.1 Diltiazem Hydrochloride Injection Type Introduction
  2. 4.1.1 10mg/1ml
  3. 4.1.2 10mg/2ml
  4. 4.2 Global Diltiazem Hydrochloride Injection Sales by Type
  5. 4.2.1 Global Diltiazem Hydrochloride Injection Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Diltiazem Hydrochloride Injection Sales by Type (2021-2032)
  7. 4.2.3 Global Diltiazem Hydrochloride Injection Sales Market Share by Type (2021-2032)
  8. 4.3 Global Diltiazem Hydrochloride Injection Revenue by Type
  9. 4.3.1 Global Diltiazem Hydrochloride Injection Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Diltiazem Hydrochloride Injection Revenue by Type (2021-2032)
  11. 4.3.3 Global Diltiazem Hydrochloride Injection Revenue Market Share by Type (2021-2032)
5 Diltiazem Hydrochloride Injection Market by Application
  1. 5.1 Diltiazem Hydrochloride Injection Application Introduction
  2. 5.1.1 Cardiovascular System Diseases
  3. 5.1.2 Surgery-Related Applications
  4. 5.2 Global Diltiazem Hydrochloride Injection Sales by Application
  5. 5.2.1 Global Diltiazem Hydrochloride Injection Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Diltiazem Hydrochloride Injection Sales by Application (2021-2032)
  7. 5.2.3 Global Diltiazem Hydrochloride Injection Sales Market Share by Application (2021-2032)
  8. 5.3 Global Diltiazem Hydrochloride Injection Revenue by Application
  9. 5.3.1 Global Diltiazem Hydrochloride Injection Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Diltiazem Hydrochloride Injection Revenue by Application (2021-2032)
  11. 5.3.3 Global Diltiazem Hydrochloride Injection Revenue Market Share by Application (2021-2032)
6 Global Diltiazem Hydrochloride Injection Sales by Region
  1. 6.1 Global Diltiazem Hydrochloride Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Diltiazem Hydrochloride Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Diltiazem Hydrochloride Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Diltiazem Hydrochloride Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Diltiazem Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Diltiazem Hydrochloride Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Diltiazem Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Diltiazem Hydrochloride Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Diltiazem Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Diltiazem Hydrochloride Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Diltiazem Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Diltiazem Hydrochloride Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Diltiazem Hydrochloride Injection Revenue by Region
  1. 7.1 Global Diltiazem Hydrochloride Injection Revenue by Region
  2. 7.1.1 Global Diltiazem Hydrochloride Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Diltiazem Hydrochloride Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Diltiazem Hydrochloride Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Diltiazem Hydrochloride Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Diltiazem Hydrochloride Injection Revenue (2021-2032)
  8. 7.2.2 North America Diltiazem Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Diltiazem Hydrochloride Injection Revenue (2021-2032)
  11. 7.3.2 Europe Diltiazem Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Diltiazem Hydrochloride Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Diltiazem Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Diltiazem Hydrochloride Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Diltiazem Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhejiang Yatai Pharmaceutical
  2. 8.1.1 Zhejiang Yatai Pharmaceutical Company Information
  3. 8.1.2 Zhejiang Yatai Pharmaceutical Business Overview
  4. 8.1.3 Zhejiang Yatai Pharmaceutical Diltiazem Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zhejiang Yatai Pharmaceutical Diltiazem Hydrochloride Injection Product Portfolio
  6. 8.1.5 Zhejiang Yatai Pharmaceutical Recent Developments
  7. 8.2 Shanghai Pharmaceuticals
  8. 8.2.1 Shanghai Pharmaceuticals Company Information
  9. 8.2.2 Shanghai Pharmaceuticals Business Overview
  10. 8.2.3 Shanghai Pharmaceuticals Diltiazem Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Shanghai Pharmaceuticals Diltiazem Hydrochloride Injection Product Portfolio
  12. 8.2.5 Shanghai Pharmaceuticals Recent Developments
  13. 8.3 SHANDONG FANGMING BANGJIA PHARMACEUTICAL
  14. 8.3.1 SHANDONG FANGMING BANGJIA PHARMACEUTICAL Company Information
  15. 8.3.2 SHANDONG FANGMING BANGJIA PHARMACEUTICAL Business Overview
  16. 8.3.3 SHANDONG FANGMING BANGJIA PHARMACEUTICAL Diltiazem Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 SHANDONG FANGMING BANGJIA PHARMACEUTICAL Diltiazem Hydrochloride Injection Product Portfolio
  18. 8.3.5 SHANDONG FANGMING BANGJIA PHARMACEUTICAL Recent Developments
  19. 8.4 Mylan Pharmaceuticals
  20. 8.4.1 Mylan Pharmaceuticals Company Information
  21. 8.4.2 Mylan Pharmaceuticals Business Overview
  22. 8.4.3 Mylan Pharmaceuticals Diltiazem Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Mylan Pharmaceuticals Diltiazem Hydrochloride Injection Product Portfolio
  24. 8.4.5 Mylan Pharmaceuticals Recent Developments
  25. 8.5 JiangSu WuZhong Pharmaceutical
  26. 8.5.1 JiangSu WuZhong Pharmaceutical Company Information
  27. 8.5.2 JiangSu WuZhong Pharmaceutical Business Overview
  28. 8.5.3 JiangSu WuZhong Pharmaceutical Diltiazem Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 JiangSu WuZhong Pharmaceutical Diltiazem Hydrochloride Injection Product Portfolio
  30. 8.5.5 JiangSu WuZhong Pharmaceutical Recent Developments
  31. 8.6 Pfizer
  32. 8.6.1 Pfizer Company Information
  33. 8.6.2 Pfizer Business Overview
  34. 8.6.3 Pfizer Diltiazem Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Diltiazem Hydrochloride Injection Product Portfolio
  36. 8.6.5 Pfizer Recent Developments
  37. 8.7 Torrent Pharmaceuticals
  38. 8.7.1 Torrent Pharmaceuticals Company Information
  39. 8.7.2 Torrent Pharmaceuticals Business Overview
  40. 8.7.3 Torrent Pharmaceuticals Diltiazem Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Torrent Pharmaceuticals Diltiazem Hydrochloride Injection Product Portfolio
  42. 8.7.5 Torrent Pharmaceuticals Recent Developments
  43. 8.8 SGPharma
  44. 8.8.1 SGPharma Company Information
  45. 8.8.2 SGPharma Business Overview
  46. 8.8.3 SGPharma Diltiazem Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 SGPharma Diltiazem Hydrochloride Injection Product Portfolio
  48. 8.8.5 SGPharma Recent Developments
  49. 8.9 SagentPharma
  50. 8.9.1 SagentPharma Company Information
  51. 8.9.2 SagentPharma Business Overview
  52. 8.9.3 SagentPharma Diltiazem Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 SagentPharma Diltiazem Hydrochloride Injection Product Portfolio
  54. 8.9.5 SagentPharma Recent Developments
  55. 8.10 Nova Plus Pharmaceuticals
  56. 8.10.1 Nova Plus Pharmaceuticals Company Information
  57. 8.10.2 Nova Plus Pharmaceuticals Business Overview
  58. 8.10.3 Nova Plus Pharmaceuticals Diltiazem Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Nova Plus Pharmaceuticals Diltiazem Hydrochloride Injection Product Portfolio
  60. 8.10.5 Nova Plus Pharmaceuticals Recent Developments
  61. 8.11 Hikma Pharmaceuticals
  62. 8.11.1 Hikma Pharmaceuticals Company Information
  63. 8.11.2 Hikma Pharmaceuticals Business Overview
  64. 8.11.3 Hikma Pharmaceuticals Diltiazem Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Hikma Pharmaceuticals Diltiazem Hydrochloride Injection Product Portfolio
  66. 8.11.5 Hikma Pharmaceuticals Recent Developments
  67. 8.12 Eugia US
  68. 8.12.1 Eugia US Company Information
  69. 8.12.2 Eugia US Business Overview
  70. 8.12.3 Eugia US Diltiazem Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Eugia US Diltiazem Hydrochloride Injection Product Portfolio
  72. 8.12.5 Eugia US Recent Developments
  73. 8.13 AdvaCare Pharma
  74. 8.13.1 AdvaCare Pharma Company Information
  75. 8.13.2 AdvaCare Pharma Business Overview
  76. 8.13.3 AdvaCare Pharma Diltiazem Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 AdvaCare Pharma Diltiazem Hydrochloride Injection Product Portfolio
  78. 8.13.5 AdvaCare Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Diltiazem Hydrochloride Injection Value Chain Analysis
  2. 9.1.1 Diltiazem Hydrochloride Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Diltiazem Hydrochloride Injection Production Mode & Process
  6. 9.2 Diltiazem Hydrochloride Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Diltiazem Hydrochloride Injection Distributors
  9. 9.2.3 Diltiazem Hydrochloride Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst